Hep C Cure Aside, Some Patients Still Benefit From Liver Cancer Screening
(MedPage Today) -- Hepatocellular carcinoma (HCC) risk declined but remained high enough for screening in the first 7 years for some patients cured of their hepatitis C virus infections with direct-acting antivirals, an observational study showed...
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Liver | Liver Cancer | Primary Care | Study | Urology & Nephrology